Key Trends Driving the US PARP Inhibitor Biomarkers Testing Product...

adicionou um novo artigo Health

2026-06-29 09:16:43 -

Key Trends Driving the US PARP Inhibitor Biomarkers Testing Product Market Expansion

The United States represents the largest share of the PARP inhibitor biomarkers testing product market, driven by its advanced healthcare infrastructure, strong adoption of precision oncology, and high prevalence of cancer. The country has witnessed increasing utilization of biomarker testing solutions for identifying BRCA mutations and homologous recombination deficiency (HRD) in patients...

0 Comentários 0 Compartilhamentos 39 Visualizações 0 Anterior